Journal profile · Medicine-Medicine (miscellaneous)
Current Opinion in Biomedical Engineering
ISSN 2468-4511 · Elsevier
Current Opinion in Biomedical Engineering: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.77; hybrid open access; APC about USD 3,830; review about 129 days (submission to acceptance, publisher); 70 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current Opinion in Biomedical Engineering is published by Elsevier and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are 3D Printing in Biomedical Research, Neuroscience and Neural Engineering and Electrospun Nanofibers in Biomedical Applications, together about 27.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Current Opinion in Biomedical Engineering provides systematic and focused reviews of the latest developments in different areas of the field of biomedical engineering. The Journal editors invite experts to evaluate the most innovative and interdisciplinary advances published in the previous 2 years. In addition to describing recent trends, authors will provide their subjective opinion on the topics discussed.Themed Sections: Each issue will review up to two of the major themes of biomedical engineering outlined below. In doing so, the Journal will serve as an invaluable resource to help bridge knowledge gaps amongst the researchers, academics, clinicians, professionals, and students with specializations in the various sub-disciplines of this field.BiomaterialsBiomechanics and mechanobiologyBiomedical imagingFuture of biomedical engineeringMolecular and cellular engineeringNeural engineeringNovel biomedical technologiesTissue engineering and regenerative medicineSelection of the topics to be reviewed: Section editors, who are major authorities in the field, are appointed by the Editor-in-Chief of the journal. They divide their section into a number of topics representing key subfields of the discipline, ensuring that the field is comprehensively covered and that all issues of current importance are emphasized. Section Editors, together with specialist Guest Editors, commission reviews from authorities on each topic that they have selected with the aim to stimulate exchange of ideas amongst experts. Editorial Board members are experts in the various subfields of the discipline, and support the Section Editors in the identification of important topical areas, Guest Editors, and prospective authors.Editorial Overview: Section Editors, together with the Guest Editors, will write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Medicine (miscellaneous)
Editor-in-chief George TruskeyPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 35, Germany 6, Australia 4, United Kingdom 2, Netherlands 2 (54 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- 3D Printing in Biomedical ResearchEngineering15.1%
- Neuroscience and Neural EngineeringNeuroscience6.4%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science5.9%
- Tissue Engineering and Regenerative MedicineMedicine5.9%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology5.7%
- Cellular Mechanics and InteractionsBiochemistry, Genetics and Molecular Biology5.2%
- Bone Tissue Engineering MaterialsEngineering4.5%
- Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Engineering, Biomedical | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Engineering, Biomedical | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Engineering Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Engineering | Zone 3 |
| Minor | Engineering, Biomedical | Zone 4 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.77LetPub ·
- Impact factor (publisher)
- 3.8Publisher website ·
- CiteScore 2026-06
- 8.9LetPub ·
- CiteScore (publisher)
- 8.9Publisher website ·
- SJR 2026-06
- 0.85LetPub ·
- SNIP 2026-06
- 0.75LetPub ·
- h-index
- 61OpenAlex ·
- i10-index
- 335OpenAlex ·
- 2-year mean citedness
- 3.83OpenAlex ·
- Self-citation rate
- 2.6%LetPub ·
- Share of gold OA articles
- 29.11%LetPub ·
Volume
- Articles per year
- 53LetPub ·
Articles by year OpenAlex count · 694 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 34 | 17 | 37 |
| 2025 | 70 | 35 | 317 |
| 2024 | 52 | 31 | 243 |
| 2023 | 75 | 40 | 947 |
| 2022 | 72 | 40 | 1,113 |
| 2021 | 102 | 52 | 2,152 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
129 dayssubmission to acceptance
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Submission to first decision
- 19 daysPublisher website ·
- First decision after review
- 81 daysPublisher website ·
- Submission to acceptance
- 129 daysPublisher website ·
- Acceptance to publication
- 6 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,830 / EUR 3,580 / GBP 3,070 / JPY 475,030 | — | — | |
| Publisher website | USD 4,040 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 2,000 words
- Reference style
- Numbered, in order of citation
- Highlights
- Optional
Article types accepted3, with length limits
- invited review articlesInvited review articles: Authors write short review articles (2000 words or about 5-10 printed pages with figures) in which they present most recent development…Length not stated
- opinione into account when preparing a Current Opinion paper: 2000 word limit (excluding abstract, references and figure captions)main text ≤ 2,000 words
- review articleing developments. Article types Invited review articles: Authors write short review articles (2000 words or about 5-10 printed pages with figures) in which they…main text ≤ 2,000 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
Submissions are by invitation only. Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process; submissions initially assessed by editors, then typically reviewed by a minimum of two reviewers; decision made by editors. Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 2468-4511
- Official links
- Journal homepage ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Current Opinion in Biomedical Engineering
What CAS zone is Current Opinion in Biomedical Engineering in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Opinion in Biomedical Engineering is in Zone 3 of Medicine, and in Zone 4 of the minor category Engineering, Biomedical. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Opinion in Biomedical Engineering?
The latest impact factor listed by LetPub is 3.77; CiteScore 8.9, h-index 61.
How long does peer review take at Current Opinion in Biomedical Engineering?
The publisher reports about 129 days (submission to acceptance). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Current Opinion in Biomedical Engineering?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 2,000 words; Reference style: Numbered, in order of citation; Highlights: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Current Opinion in Biomedical Engineering based?
Of the 54 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (35), Germany (6) and Australia (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Current Opinion in Biomedical Engineering?
According to LetPub and DOAJ records, Current Opinion in Biomedical Engineering is indexed in SCIE and Scopus.
Is Current Opinion in Biomedical Engineering open access, and what is the APC?
Current Opinion in Biomedical Engineering is a hybrid journal. For open-access publication: APC about USD 3,830.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .